The studies showing that the relative expression of PPARβ/δ was lower in colon tumors as compared with non-transformed tissue provide strong weight of evidence for the field because they included larger sample sizes, included positive and negative controls, quantitatively examined protein expression, are consistent with large, publicly available databases, and directly compared models with defective APC signaling. This evidence concerns the gene APC and colonic neoplasm.